Updated: May 10
Derek is a result-driven professional, proactive, and agile technical programme manager with more than 22 years of international experience.
With a successful track record of taking projects from concept to commercialisation, primarily in the medical device and ophthalmic Industries.
Derek has a BSc (Hons) in Polymer Science and Technology and a Master of Business Administration (MBA).
We had a chat with him and got some interesting insights! Read all about it below!
When did you get involved with Occuity? Why did you feel it was the right thing for you?
September 2020. It’s rare to find opportunities whereby there is a credible product/s with protected IP, suitable financial backing, strong credible leadership in a market which fundamentally can improve wellbeing. The opportunity at Occuity provided just that and was well suited to my knowledge, expertise, and desire to deliver a difference to the world.
How do you feel about the situation right now?
I know very little about the crowed funding, but it really helps product development when investors understand the day-to-day issues with the current technology and are willing to invest in new technology, which can improve their wellbeing. The personal stake and valuable insight they can provide is far beyond the financial and the reward for the team delivering the product is greatly enhanced.
Why are you confident Occuity will be a success?
Occuity has novel technology which provides the eye care practician a simple cost-effective solution to measuring Central Corneal Thickness naturally there will be challenges faced as with any new technology development, but the core technology is proven. And with an experienced and knowledge of the management team the product will come to market in a timely manner.
How do you think will Occuity’s future look like?
Development is always challenging, but I believe that Occuity has the building blocks to be a very successful business in the diagnostics, monitoring and optical instrument healthcare market.